Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists

✍ Scribed by L. A. Bradbury; S. Barlow; F. Geoghegan; R. A. Hannon; S. L. Stuckey; J. A. H. Wass; R. G. G. Russell; M. A. Brown; E. L. Duncan

• Publisher: Springer-Verlag
• Year: 2011
• Tongue: English
• Weight: 177 KB
• Volume: 23
• Category: Article
• ISSN: 0937-941X
• DOI: 10.1007/s00198-011-1658-2